Research Article

Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production

Table 2

Effects of caffeamide 36-13 (TS) on absolute tissue weight, food intake, liver lipids and blood profiles.

ParameterCONHFHF + T1HF + T2HF + Rosi
0.01a0.02a0.01a

Absolute tissue weight (g)
 EWAT
 MWAT
 RWAT
 Visveral fat
 BAT
 Liver (g)
 Spleen
 Weight gain (g)
 Food intake (g/day/mouse)
Liver lipids
 total lipid (mg/g)
 Triacylglycerol ( mol/g)
Blood profiles
 Glucose levels (mg/dL)
 Triglycerides (mg/dL)
 FFA (meq/L)
 TC (mg/dL)
 Insulin ( U/mL)
 Adiponectin (ng/mL)
 Leptin ( g/mL)

All values are means ± S.E. ( ). , , compared with the control (CON) group; , , compared with the high-fat + vehicle (distilled water) (HF) group. TS: T1: 0.01, T2: 0.02 g/kg bodyweight; Rosi: rosiglitazone (0.01 g/kg body weight). BAT, brown adipose tissue; RWAT, retroperioneal white adipose tissue; MWAT, mesenteric white adipose tissue; FFA, plasma free fatty acid; TC, total cholesterol; TG, triglyceride. aDose (g/kg/day).